Prostate Brachytherapy with Iodine-125 Seeds: Radiation Protection Issues
- 1 July 2005
- journal article
- other
- Published by SAGE Publications in Tumori Journal
- Vol. 91 (4) , 335-338
Abstract
Aims and background: Brachytherapy for prostate cancer by means of permanently implanted 125 I sources is a well established procedure. An increasing number of patients all over the world are treated with this modality. When the technique was introduced at our institution, radiation protection issues relative to this technique were investigated in order to comply with international recommendations and national regulations. Particular attention was paid to the need for patient shielding after discharge from hospital. Methods: The effective and equivalent doses to personnel related to implantation, the effective dose to patient relatives as computed by a developed algorithm, the air kerma strength values for the radioactive sources certified by the manufacturer compared with those measured by a well chamber, and the effectiveness of lead gloves in shielding the hands were evaluated. Results: The effective dose to the bodies of personnel protected by a lead apron proved to be negligible. The mean equivalent doses to the physician's hands was 420 μSv for one implant; the technician's hands received 65 μSv. The mean air kerma rate measured at the anterior skin surface of the patient who had received an implant was 55 μGy/h (range, 10–115) and was negligible with lead protection. The measured and certified air kerma strength for 125I seeds in RAPID Strand corresponded within a margin of ± 5%. The measured attenuation by lead gloves in operative conditions was about 80%. We also defined the recommendations to be given to the patient at discharge. Conclusions: The exposure risks related to brachytherapy with 125I to operators and public are limited. However, alternation of operators should be considered to minimize exposure. Patient-related measurements should verify the dose rate around the patient to evaluate the need for shielding and to define appropriate radiation protection recommendations.Keywords
This publication has 10 references indexed in Scilit:
- Radiation exposure to family and household members after prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Radiation safety issues regarding the cremation of the body of an I-125 prostate implant patientJournal of Applied Clinical Medical Physics, 2001
- ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancerRadiotherapy and Oncology, 2000
- Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64Medical Physics, 1999
- Radiation safety parameters following prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc SubcommitteeMedical Physics, 1999
- Quality Assurance Calibration of 125I Rapid Strand in a Sterile EnvironmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56Medical Physics, 1997
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995